iSpecimen Inc. Capitalized Computer Software, Additions
iSpecimen Inc. (ISPC) reported Capitalized Computer Software, Additions of $1.00 million for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Goodwill and Other
us-gaap:CapitalizedComputerSoftwareAdditions · last filed 2026-08-14
- iSpecimen Inc. capitalized computer software, additions for the quarter ending 2024-12-31 was $65.19K, a 75.50% decline year-over-year.
- iSpecimen Inc. capitalized computer software, additions for the quarter ending 2024-09-30 was $140.41K, a 81.76% decline year-over-year.
- iSpecimen Inc. capitalized computer software, additions for the quarter ending 2024-06-30 was $172.20K, a 85.55% decline year-over-year.
- iSpecimen Inc. capitalized computer software, additions for the quarter ending 2024-03-31 was $275.49K, a 82.11% decline year-over-year.
- iSpecimen Inc. capitalized computer software, additions for fiscal 2024 was $653.29K, a 82.66% decline from fiscal 2023.
- iSpecimen Inc. capitalized computer software, additions for fiscal 2023 was $3.77M, a 26.60% increase from fiscal 2022.
- iSpecimen Inc. capitalized computer software, additions for fiscal 2022 was $2.98M, a 187.40% increase from fiscal 2021.
- iSpecimen Inc. capitalized computer software, additions for fiscal 2021 was $1.04M, a 6.06% decline from fiscal 2020.
| Period end | Capitalized Computer Software, Additions 3 month | Capitalized Computer Software, Additions 6 month | Capitalized Computer Software, Additions 6 month as first filed | Capitalized Computer Software, Additions 9 month | Capitalized Computer Software, Additions 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $1.00M 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | $65.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $205.60K derived: sum of 2 quarters · filed 2026-04-01 | $377.80K derived: sum of 3 quarters · filed 2026-04-01 | $653.29K 10-K · filed 2026-04-01 | |
| 2024-09-30 | $140.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $312.61K derived: sum of 2 quarters · filed 2024-11-07 | $588.09K 10-Q · filed 2024-11-07 | $854.22K derived: sum of 4 quarters · filed 2025-04-14 | |
| 2024-06-30 | $172.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $447.69K 10-Q · filed 2024-08-06 | $713.81K derived: sum of 3 quarters · filed 2025-04-14 | $1.48M derived: sum of 4 quarters · filed 2025-04-14 | |
| 2024-03-31 | $275.49K 10-Q · filed 2024-05-07 | $541.61K derived: sum of 2 quarters · filed 2025-04-14 | $1.31M derived: sum of 3 quarters · filed 2025-04-14 | $2.50M derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-12-31 | $266.13K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $1.04M derived: sum of 2 quarters · filed 2025-04-14 | $2.23M derived: sum of 3 quarters · filed 2025-04-14 | $3.77M 10-K · filed 2025-04-14 | |
| 2023-09-30 | $769.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.96M derived: sum of 2 quarters · filed 2024-11-07 | $3.50M 10-Q · filed 2024-11-07 | $4.93M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.73M 10-Q · filed 2024-08-06 | $4.16M derived: sum of 3 quarters · filed 2024-08-06 | $4.94M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $1.54M 10-Q · filed 2024-05-07 | $2.97M derived: sum of 2 quarters · filed 2024-05-07 | $3.74M derived: sum of 3 quarters · filed 2024-05-07 | $4.18M derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.20M derived: sum of 2 quarters · filed 2024-03-13 | $2.64M derived: sum of 3 quarters · filed 2024-03-13 | $2.98M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $778.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.21M derived: sum of 2 quarters · filed 2023-11-02 | $1.55M 10-Q · filed 2023-11-02 | $1.85M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $432.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $771.18K 10-Q · filed 2023-08-02 | $777.18K 10-Q · filed 2022-08-04 | $1.08M derived: sum of 3 quarters · filed 2023-08-02 | $1.37M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $339.16K 10-Q · filed 2023-05-04 | $643.36K derived: sum of 2 quarters · filed 2023-05-04 | $934.20K derived: sum of 3 quarters · filed 2023-05-04 | $1.17M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $304.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $595.04K derived: sum of 2 quarters · filed 2023-03-30 | $831.39K derived: sum of 3 quarters · filed 2023-03-30 | $1.04M 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $290.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $527.20K derived: sum of 2 quarters · filed 2022-11-08 | $731.17K 10-Q · filed 2022-11-08 | $979.00K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $236.35K 10-Q · filed 2021-08-10 | $440.33K 10-Q · filed 2022-08-04 | $688.15K derived: sum of 3 quarters · filed 2022-05-10 | $962.06K derived: sum of 4 quarters · filed 2022-05-10 | |
| 2021-03-31 | $214.53K 10-Q · filed 2022-05-10 | $451.80K derived: sum of 2 quarters · filed 2022-05-10 | $725.70K derived: sum of 3 quarters · filed 2022-05-10 | $939.45K derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $237.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $511.17K derived: sum of 2 quarters · filed 2022-03-22 | $724.92K derived: sum of 3 quarters · filed 2022-03-22 | $1.10M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $273.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $487.65K derived: sum of 2 quarters · filed 2021-11-04 | $864.92K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $213.75K 10-Q · filed 2021-08-10 | $591.02K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |